In this work simultaneous T1 and T2 mapping via MR Fingerprinting was used to observe the distribution of dysprosium and gadolinium MRI contrast agents in a mouse tumor model. Changes from baseline in T1 and T2 were observed using each agent alone and an increased effect was seen when agents were used in combination. Additionally, a decrease in the dysprosium dose lead to a reduction in the level of T1 and T2 enhancement observed. These results indicate that MRF might be able to be used to track multiple MRI contrast agents in vivo.
This abstract and the presentation materials are available to members only; a login is required.